Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Altynay Shigayeva

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Influenza and Other Respiratory Viruses|January 13, 2026
Early COVID-19 and Severity of Subsequent Omicron Infection in Ontario CanadaCaroline Kassee, Altynay Shigayeva, Christopher Kandel, et al.
BMC Infectious Diseases|January 28, 2025
Identification of patient demographic, clinical, and SARS-CoV-2 genomic factors associated with severe COVID-19 using supervised machine learning: a retrospective multicenter studyKuganya Nirmalarajah, Patryk Aftanas, Shiva Barati, et al.
Emerging Infectious Diseases|June 12, 2023
Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, CanadaRajesh Abraham Jacob, Ali Zhang, Hannah O Ajoge, et al.
Microbiology Spectrum|November 17, 2021
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization AssaysEmelissa J Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
Vaccine|March 5, 2026
Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 eraAltynay Shigayeva, Brenda L Coleman, Alyssa R Golden, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Influenza and Other Respiratory Viruses|January 13, 2026
Early COVID-19 and Severity of Subsequent Omicron Infection in Ontario CanadaCaroline Kassee, Altynay Shigayeva, Christopher Kandel, et al.
BMC Infectious Diseases|January 28, 2025
Identification of patient demographic, clinical, and SARS-CoV-2 genomic factors associated with severe COVID-19 using supervised machine learning: a retrospective multicenter studyKuganya Nirmalarajah, Patryk Aftanas, Shiva Barati, et al.
Emerging Infectious Diseases|June 12, 2023
Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, CanadaRajesh Abraham Jacob, Ali Zhang, Hannah O Ajoge, et al.
Microbiology Spectrum|November 17, 2021
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization AssaysEmelissa J Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
Vaccine|March 5, 2026
Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 eraAltynay Shigayeva, Brenda L Coleman, Alyssa R Golden, et al.
Pageof 3